2019年12月10日星期二

A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials

A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials

J Tillner, MG Posch, F Wagner… - Diabetes, Obesity …, 2019 - Wiley Online Library
Aims To evaluate the safety, pharmacokinetics and pharmacodynamics of SAR425899, a
novel polypeptide, active as an agonist at both the glucagon‐like peptide‐1 receptor (GLP‐
1R) and the glucagon receptor (GCR), in healthy volunteers and in overweight/obese …


For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to >99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.

Eva He
eva@pepmic.com
Pepmic Co., Ltd
www.pepmic.com


没有评论:

发表评论